Gala vs GoodRx Care: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Gala beats GoodRx Care overall, scoring 7/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $149/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke.
A side-by-side comparison of Gala and GoodRx Care covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaGoodRx Care
#42 of 42GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx Care| Feature | Gala | GoodRx Care |
|---|---|---|
| Our Score | 7/10 | 6.2/10 |
| Starting Price | $149/mo | $119/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill |
| Ranking | #40 | #42 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
GoodRx Care
Pros
- +2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
- +Insurance accepted — GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
Our Verdict
Gala edges out GoodRx Care with a score of 7/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Gala's $149/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill.